Mumbai, October 2, 2023: FlexifyMe, a pioneering health-tech platform dedicated to chronic pain management, has successfully closed its Seed funding round, raising $1 million with leading investment from Flipkart Ventures, Flipkart’s venture investing arm.
This funding round will significantly help the company in fast growth. FlexifyMe has grown by almost 5X in the last 12 months. While the investment was led by Flipkart Ventures, it was followed by other notable participants like GSF, iHub Anubhuti, Chandigarh Angels (CAN), Venture Catalyst, and OneCapital among other prominent angels. The funds from this round will be used to further enhance the AI motion coach, making it available in local languages, and expanding the platform’s reach in the MENA and North American regions. Apart from seed fund investors, the existing backers of FlexifyMe include individuals like Ravi Bhushan, the founder of BrightChamps, & Amit Ratanpal, the founder of BlincInvest among several other supporters.
Founded in Oct 2021 by serial entrepreneurs Manjeet Singh and Amit Bhayani, FlexifyMe is on a mission to transform traditional physiotherapy approaches with its innovative AI motion-tracking technology. FlexifyMe’s focus is to use technology and ancient wisdom to help people in getting rid of musculoskeletal disorders (MSK) such as back pain, spondylitis, arthritis, knee pain and others in a natural way to free the world from pain.’
Manjeet Singh, Co-founder of FlexifyMe, said, “We’re thrilled by the tremendous support we’ve received in this funding round, which increases our confidence of using technology to help people live a pain-free life. I myself have gone through the painful cycle when I was diagnosed with Lumbar Spondylitis in 2016. After going through a non-standardized approach by different physiotherapists my condition deteriorated and doctors suggested Surgery. I was able to cure myself naturally using the 360 Flex approach and now we are on the mission to make chronic pain management outcome-oriented and more scientific. We’re committed to leveraging technology to improve the lives of millions suffering from chronic pain, and this funding takes us a significant step closer to achieving that goal.”
With a commitment to seamlessly integrating technology and healthcare, FlexifyMe is poised for expansion and enhancements, with a strong vision to make its services more accessible and effective for a global audience. Key Venture played a vital role as a transaction advisor in the round.
Lubna Ahmed, Head of Flipkart Ventures, said, “Flipkart has always been at the forefront of empowering the startup ecosystem in India. We are excited to witness the transformative journey of startups in India as they harness Flipkart’s resources and guidance to bring their innovative ideas to life. We are pleased to invest in Flexifyme as it continues to fuel innovation and growth in its industry. The investment is being made by Flipkart Ventures through its cohort-based Leap Ahead program.”
Amit Bhayani, Co-founder of FlexifyMe, said, “Our mission is to leverage advanced technology for healthcare, and this funding reaffirms our commitment. Our platform tracks real-time patient movement and adapts exercises to boost engagement. Through AI, machine learning, and data analytics, we offer personalized Chronic Pain Management. We’re excited about expansion and tech upgrades that will enhance global accessibility and effectiveness. The future is bright, and we are committed to pushing the boundaries of what’s possible for the betterment of humanity!”
“We are committed to making FlexifyMe the next big company from India in chronic pain management serving the global population.”
FlexifyMe has set ambitious goals for the future. In the short term, the company is diligently working towards achieving clinical validation and securing approval from the FDA, a pivotal step that will enhance its credibility within the medical field. In the long term, FlexifyMe is focused on forging strategic partnerships with insurance companies, hospitals, and multinational corporations (MNCs). These visionary objectives underscore FlexifyMe’s commitment to revolutionizing chronic pain management and ensuring accessibility to its innovative solutions on a global scale.